Cite
HARVARD Citation
Mandala, M. et al. (2021). SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. Journal for immunotherapy of cancer. 9 (2), p. . [Online].